loading
전일 마감가:
$5.75
열려 있는:
$5.79
하루 거래량:
63,744
Relative Volume:
1.10
시가총액:
$94.16M
수익:
-
순이익/손실:
$-14.88M
주가수익비율:
-5.9694
EPS:
-0.98
순현금흐름:
$-10.29M
1주 성능:
+1.04%
1개월 성능:
+9.76%
6개월 성능:
+2.09%
1년 성능:
-4.10%
1일 변동 폭
Value
$5.64
$6.23
1주일 범위
Value
$5.58
$6.34
52주 변동 폭
Value
$4.65
$10.24

Coya Therapeutics Inc Stock (COYA) Company Profile

Name
명칭
Coya Therapeutics Inc
Name
전화
650.739.3939
Name
주소
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
Name
직원
8
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
COYA's Discussions on Twitter

COYA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
COYA
Coya Therapeutics Inc
5.9334 94.16M 0 -14.88M -10.29M -0.98
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.25 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.21 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.42 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
555.31 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
246.33 28.51B 3.81B -644.79M -669.77M -6.24

Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-04 개시 D. Boral Capital Buy

Coya Therapeutics Inc 주식(COYA)의 최신 뉴스

pulisher
Jun 18, 2025

Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025 - Business Wire

Jun 18, 2025
pulisher
Jun 18, 2025

Trading (COYA) With Integrated Risk Controls - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 10, 2025

Coya Therapeutics (NASDAQ:COYA) Receives Buy Rating from HC Wainwright - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Coya Therapeutics (COYA) Receives Confirmed Buy Rating from HC W - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Coya Therapeutics (COYA) Receives Confirmed Buy Rating from HC Wainwright | COYA Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Coya Therapeutics (COYA) Rated Buy by Analyst with $20 Target | COYA Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Makes New $74,000 Investment in Coya Therapeutics, Inc. (NASDAQ:COYA) - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

(COYA) Trading Report - news.stocktradersdaily.com

Jun 05, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Has $164,000 Stock Position in Coya Therapeutics, Inc. (NASDAQ:COYA) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Coya Therapeutics secures patent for IL-2 liquid formulation By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 02, 2025

Coya Therapeutics secures patent for IL-2 liquid formulation - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Coya Therapeutics (COYA) Secures U.S. Patent for IL-2 Liquid Formulation | COYA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Coya's Exclusive Patent Win Strengthens IL-2 Drug Pipeline as Phase 2b ALS Trial Approaches - Stock Titan

Jun 02, 2025
pulisher
May 26, 2025

(COYA) Investment Report - news.stocktradersdaily.com

May 26, 2025
pulisher
May 22, 2025

Brokers Issue Forecasts for COYA Q1 Earnings - Defense World

May 22, 2025
pulisher
May 22, 2025

Q3 EPS Forecast for Coya Therapeutics Increased by Analyst - Defense World

May 22, 2025
pulisher
May 20, 2025

Coya Therapeutics Reports First Quarter Financial Results and Provides a Corporate Update - Business Wire

May 20, 2025
pulisher
May 19, 2025

Coya Therapeutics: Promising Developments and Strategic Partnerships Drive Buy Rating - TipRanks

May 19, 2025
pulisher
May 19, 2025

Coya Therapeutics First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

May 19, 2025
pulisher
May 18, 2025

FY2026 Earnings Forecast for COYA Issued By Chardan Capital - Defense World

May 18, 2025
pulisher
May 16, 2025

Coya Therapeutics to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference - Business Wire

May 16, 2025
pulisher
May 16, 2025

Coya Therapeutics, Inc. (NASDAQ:COYA) Stock Holdings Lifted by Tower Research Capital LLC TRC - Defense World

May 16, 2025
pulisher
May 14, 2025

Coya Therapeutics (COYA): Analyst Maintains Buy Rating and Price - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Critical Survey: Coya Therapeutics (NASDAQ:COYA) vs. BioVie (NASDAQ:BIVI) - Defense World

May 14, 2025
pulisher
May 14, 2025

Coya Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 14, 2025
pulisher
May 13, 2025

Coya (COYA) Reports Lower Q1 Revenue Than Expected | COYA Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Coya Therapeutics (COYA) Reports Q1 EPS and Cash Position - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Coya Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 13, 2025
pulisher
May 08, 2025

Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025 - Stock Titan

May 08, 2025
pulisher
May 07, 2025

Coya Therapeutics (COYA) Projected to Post Quarterly Earnings on Thursday - Defense World

May 07, 2025
pulisher
May 05, 2025

How To Trade (COYA) - news.stocktradersdaily.com

May 05, 2025
pulisher
May 02, 2025

Coya Therapeutics, Inc. (NASDAQ:COYA) Shares Acquired by Geode Capital Management LLC - Defense World

May 02, 2025
pulisher
May 01, 2025

Coya Therapeutics advances COYA 303 for inflammatory diseases - MSN

May 01, 2025
pulisher
Apr 29, 2025

Is Coya Therapeutics, Inc. (COYA) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Apr 29, 2025
pulisher
Apr 29, 2025

Coya Therapeutics’ (COYA) “Buy” Rating Reaffirmed at Chardan Capital - Defense World

Apr 29, 2025
pulisher
Apr 25, 2025

Biotech Company Reports Promising Neurological Treatment in Clinical Study - streetwisereports.com

Apr 25, 2025
pulisher
Apr 25, 2025

Coya Therapeutics: Treg Proof-Of-Concept Continues With Interim FTD Data Release - Seeking Alpha

Apr 25, 2025
pulisher
Apr 24, 2025

Coya Therapeutics Announce Positive Interim Result from - openPR.com

Apr 24, 2025
pulisher
Apr 24, 2025

Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia – EventsNewsAsia.com - eventsnewsasia.com

Apr 24, 2025
pulisher
Apr 24, 2025

Biotech Discovers Revolutionary Immunotherapy in Houston - streetwisereports.com

Apr 24, 2025
pulisher
Apr 24, 2025

Coya stock in focus after interim results for dementia drug - Seeking Alpha

Apr 24, 2025
pulisher
Apr 24, 2025

Coya Reports Positive Data From Proof Of Concept Open-label Study Of IL-2 And CTLA4-Ig Combo In FTD - Nasdaq

Apr 24, 2025
pulisher
Apr 24, 2025

Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia - businessnews.ph

Apr 24, 2025
pulisher
Apr 24, 2025

Coya Therapeutics Announces Positive Interim Results Of An Investigator-Initiated Open Label Study With Low-Dose IL-2 And CTLA4-Ig Combination Treatment In Five Patients With Mild To Moderate Frontotemporal Dementia - marketscreener.com

Apr 24, 2025
pulisher
Apr 24, 2025

Revolutionary Frontotemporal Dementia Treatment Prevents Cognitive Decline in All Trial Patients - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

Coya Therapeutics (NASDAQ:COYA) Earns Buy Rating from D. Boral Capital - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

Wall Street Analysts See a 144.73% Upside in Coya Therapeutics, Inc. (COYA): Can the Stock Really Move This High? - Yahoo Finance

Apr 23, 2025
pulisher
Apr 22, 2025

AI in Clinical Trials Market Growth 2025: Trends, Consumer - openPR.com

Apr 22, 2025
pulisher
Apr 22, 2025

Coya Therapeutics (NASDAQ:COYA) Trading 8.6% Higher – What’s Next? - Defense World

Apr 22, 2025
pulisher
Apr 21, 2025

Coya Therapeutics, Inc. Announces Publication of GLP-1/LD IL-2 Combination Biologic (COYA 303) Demonstrating Synergistic Enhancement of Regulatory T Cell Function and Protection Against Treg Apoptosis (Cell Death) - marketscreener.com

Apr 21, 2025

Coya Therapeutics Inc (COYA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Coya Therapeutics Inc 주식 (COYA) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Swaminathan Arun
Chief Executive Officer
Nov 13 '24
Buy
7.36
5,000
36,797
10,000
Grossman Fred
Chief Medical Officer
Nov 11 '24
Buy
7.37
2,710
19,973
2,710
Swaminathan Arun
Chief Executive Officer
Nov 11 '24
Buy
7.34
5,000
36,689
5,000
$21.00
price up icon 1.52%
$36.00
price down icon 0.06%
$21.32
price down icon 0.15%
$99.07
price down icon 1.72%
$108.80
price up icon 2.21%
biotechnology ONC
$244.86
price up icon 1.07%
자본화:     |  볼륨(24시간):